Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05645328 · ClinicalTrials.gov registry record · NA

Implementation of a Health System Intervention to Improve Quality of Cancer Care for Rural Patients

A NA study of Cancer, sponsored by Mary Charlton.

Active
Registry status
NA
Development phase
31
Enrollment target
1
Study location

NCT05645328: Active NA study of Cancer, sponsored by Mary Charlton.

NCT05645328 is a NA study of Cancer that is active but no longer recruiting, run by Mary Charlton. The registered enrollment target is 31 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05645328, a NA study of Cancer, is active but no longer recruiting, sponsored by Mary Charlton.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
31 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to implement and evaluate the recently developed Iowa Cancer Affiliate Network (ICAN) intervention. The ICAN intervention will consist of members of the research team providing ongoing support to participating hospitals in achieving the quality standards outlined by the American College of Surgeons Commission on Cancer (CoC). Support will be offered in the form of education and training regarding the standards and provision of cancer services, regular in-person and zoom check-ins with hospital stakeholders to evaluate progress, and provision of documentation and educational resources regarding standard requirements. Implementation approach:1) Engage implementation teams and develop and execute implementation plans based on hospital needs assessments; and 2) Conduct interviews with key ICAN stakeholders to assess acceptability, adoption, appropriateness and cost (based on Proctor's implementation outcomes framework) and determinants of these outcomes (e.g., hospital structure, culture, resources, capacity, readiness) based on the Consolidated Framework for Implementation Research. Evaluation approach: Using Iowa Cancer Registry data routinely collected for surveillance purposes, the investigators will compare rates of compliance with pre- and post-intervention treatment-related quality measures in target and control hospitals. The rural hospitals in Iowa that serve the most rural cancer patients and have never been accredited by the CoC were chosen for intervention targets, and all committed to participating in the study (letters of support provided). The remainder of rural hospitals that care for \>100 newly diagnosed cancer patients per year (n=5) were chosen as a comparison group. The investigators will use data routinely collected by the Iowa Cancer Registry to compare aggregate compliance with quality measures for cancer care between the hospitals included in the intervention and comparison group hospitals using a difference-in-di

Conditions Studied

Interventions

  • OTHER Iowa Cancer Affiliate Network (ICAN)

Study Locations (1)

Iowa

  • University of Iowa - Iowa City

Trial Details

FieldValue
Enrollment Target 31 participants
Start Date 2023-01-20
Est. Completion 2026-12-31
Phase NA

Sponsor

Mary Charlton

1 total trials

What the Registry Record Tells You About NCT05645328

The ClinicalTrials.gov registry entry for NCT05645328 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (99% lower). The listed sponsor is Mary Charlton, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Cancer appearing as the primary indexed condition, and to 1 intervention - of which Iowa Cancer Affiliate Network (ICAN) is the first listed.

NCT05645328 reports 1 study location spanning 1 distinct geographic area - top geographies include Iowa.

Frequently Asked Questions

What is clinical trial NCT05645328 about?

NCT05645328 is a clinical study titled "Implementation of a Health System Intervention to Improve Quality of Cancer Care for Rural Patients". The purpose of this study is to implement and evaluate the recently developed Iowa Cancer Affiliate Network (ICAN) intervention. The ICAN intervention will consist of members of the research team providing ongoing support to participating hospitals in achieving the quality standards outlined by the...

What is the current status of trial NCT05645328?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 31 participants. The study started on 2023-01-20. Estimated completion is 2026-12-31.

What conditions does trial NCT05645328 study?

This clinical trial studies the following conditions: Cancer.

What interventions are being tested in trial NCT05645328?

The interventions under investigation include: Iowa Cancer Affiliate Network (ICAN) (OTHER).

Who is sponsoring clinical trial NCT05645328?

This trial is sponsored by Mary Charlton, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05645328 being conducted?

This trial has 1 study location across Iowa. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.